Precisio Biotix Therapeutics, Inc. (Precisio) Announces the Use of Its ClyO (Staph Lysin) to Treat a Multi Drug-Resistant Prosthetic Joint Infection (PJI) Under an Expanded Access Chronic Care Management Protocol
Lysins are a promising new family of enzyme-based antimicrobials which offer unique properties compared to antibiotics
July 10, 2026